Press release
Gestational Diabetes Market Report 2023-2033 | Industry Size, Growth and Latest Insights
The 7 major gestational diabetes markets are expected to exhibit a CAGR of 4.97% during 2023-2033.
The report offers a comprehensive analysis of the gestational diabetes market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the gestational diabetes market.
Request for a Sample Copy of this Report: https://www.imarcgroup.com/gestational-diabetes-market/requestsample
The gestational diabetes market is growing, spurred by a rise in hormonal changes during pregnancy that impair blood sugar processing and insulin utilization. The prevalence of risk factors like overweight, sedentary lifestyle, familial diabetes history, and heart disease is also boosting market expansion. The increased use of anti-diabetic drugs, such as metformin and glibenclamide, to manage blood glucose levels and treat symptoms is another key growth contributor.
Non-pharmacological interventions, like a balanced diet, regular exercise, and maintaining an ideal weight, are also positively influencing the market. The shift from traditional syringe therapies to insulin pens, due to their convenience, precise dosing, blood sugar stabilization, and improved patient outcomes, is anticipated to propel the gestational diabetes market further.
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the gestational diabetes market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the gestational diabetes market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current gestational diabetes marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape :
The competitive landscape of the gestational diabetes market has been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7633&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gestational Diabetes Market Report 2023-2033 | Industry Size, Growth and Latest Insights here
News-ID: 3220870 • Views: …
More Releases from IMARC Group
List of Smartphone Companies in the Worldwide 2024 | IMARC Group
A smartphone is a mobile device that allows for increased access to internet-based services and other digital activities. Platforms such as iOS, Android, and Windows Phone support a wide selection of applications built by third-party developers. In terms of hardware, software, and a variety of mobile operating systems, smartphones are a subset of mobile phones distinct from feature phones. Smartphones offer a wide range of services, including music, video, gaming,…
Leading E-Pharmacy Companies in the Worldwide 2024 | IMARC Group
E-pharmacy, or electronic pharmacy, is a type of online retail that focuses on the sale and delivery of medicinal items via digital platforms. This strategy enables users to buy drugs and health-related items from any internet-connected device, resulting in ease, accessibility, and competitive cost. E-pharmacies serve people who reside in remote areas or have limited mobility since they reduce the need to visit a pharmacy physically. These platforms follow strict…
Top 10 Courier, Express, and Parcel Companies in the World | IMARC Group
Courier express and parcel companies are investing in advanced tracking systems, route optimization software, and automation technology to enhance efficiency and give real time visibility into parcel movements. They are focusing on reducing transit times through faster transportation methods, such as air freight or same-day delivery options due individual expectations for faster delivery. In addition, they are placing a priority on the user experience by offering user-friendly online platforms for…
Top Aquaculture Companies in The World | 2024
Global Aquaculture Companies
Aquaculture is a production system that entails raising different aquatic organisms which include fish, crustaceans, and mollusks. It consists of breeding of freshwater and seawater populations in an environment that can be either a tank, a pool or an enclosed ocean area. It is a dependable and sustainable source of seafood to meet the growing global demand for proteins. It is a significant contributor to food security because…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
